The Biosimilar Promise
Low-Cost Biosimilars Are Saving Billions, Potential Savings Are Even Greater
Low-Cost Biosimilars Are Saving Billions, Potential Savings Are Even Greater By Wayne Winegarden | October 28, 2024 READ PDF Executive Summary Since 2019, biosimilars have obtained a majority share of most markets where they compete. The combination of lower prices (both biosimilar and originator) and rising market share could have generated up to $35 billion in savings in 2024 dollars compared to an all-originator baseline based on PRI’s latest analysis. These savings demonstrate that, ...
The Biosimilar Promise
Biosimilars Often Reduce Prices by 50 Percent or More
Biosimilars Often Reduce Prices by 50 Percent or More By Wayne Winegarden | October 1, 2024 READ PDF Executive Summary In the competitive biologic markets, biosimilars have reduced average prices by 56 percent. The lower prices have reduced total expenditures by 51 percent in the competitive biologic markets even though total use is higher. Developing biosimilars is a long and costly endeavor that can take up to 9 years and $300 million. Market conditions should ...
For Third Year in a Row, PRI Survey Finds Vast Majority of Americans Are Satisfied with their Health Coverage
For Third Year in a Row, PRI Survey Finds Vast Majority of Americans Are Satisfied with their Health Coverage Just 37% Support Government Health Care Takeover SACRAMENTO – For the third year in a row, an overwhelming majority of Americans say they are satisfied with their current health coverage, based on a new national survey commissioned by the nonpartisan Pacific Research Institute, a California-based, free market think tank. 91% said they were satisfied with their ...
Trending Topics
Studies
